Wendy Nembhard
Concepts (331)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 40 | 2024 | 608 | 7.110 |
Why?
| Congenital Abnormalities | 18 | 2021 | 113 | 4.830 |
Why?
| Stillbirth | 12 | 2024 | 31 | 3.440 |
Why?
| Registries | 27 | 2023 | 554 | 3.390 |
Why?
| Gastroschisis | 7 | 2024 | 41 | 2.290 |
Why?
| Infant | 49 | 2023 | 3830 | 2.150 |
Why?
| Pregnancy | 48 | 2024 | 2641 | 2.090 |
Why?
| Infant, Newborn | 43 | 2024 | 2924 | 1.990 |
Why?
| Population Surveillance | 16 | 2023 | 183 | 1.950 |
Why?
| Prevalence | 26 | 2024 | 1026 | 1.640 |
Why?
| Infant Mortality | 7 | 2023 | 70 | 1.600 |
Why?
| Female | 93 | 2024 | 28474 | 1.540 |
Why?
| Hypospadias | 5 | 2022 | 40 | 1.540 |
Why?
| Cesarean Section | 3 | 2021 | 179 | 1.360 |
Why?
| Humans | 117 | 2024 | 54397 | 1.360 |
Why?
| Genetic Predisposition to Disease | 7 | 2022 | 570 | 1.340 |
Why?
| Child Mortality | 5 | 2020 | 13 | 1.310 |
Why?
| Infant, Small for Gestational Age | 4 | 2020 | 34 | 1.260 |
Why?
| Transposition of Great Vessels | 4 | 2024 | 24 | 1.180 |
Why?
| Child | 34 | 2023 | 7368 | 1.120 |
Why?
| Adult | 43 | 2023 | 14210 | 1.110 |
Why?
| Retrospective Studies | 30 | 2023 | 6460 | 1.100 |
Why?
| Hernia, Umbilical | 4 | 2024 | 18 | 1.090 |
Why?
| Prenatal Exposure Delayed Effects | 4 | 2021 | 173 | 1.080 |
Why?
| Case-Control Studies | 21 | 2023 | 1229 | 1.070 |
Why?
| Gestational Age | 8 | 2022 | 435 | 1.050 |
Why?
| Risk Factors | 28 | 2023 | 3937 | 0.970 |
Why?
| Maternal Exposure | 8 | 2023 | 87 | 0.950 |
Why?
| Intellectual Disability | 2 | 2023 | 150 | 0.930 |
Why?
| Policy | 1 | 2023 | 27 | 0.890 |
Why?
| Pregnancy Outcome | 4 | 2023 | 248 | 0.880 |
Why?
| Arkansas | 10 | 2022 | 2101 | 0.870 |
Why?
| Prenatal Diagnosis | 6 | 2021 | 113 | 0.860 |
Why?
| Child, Preschool | 19 | 2021 | 4158 | 0.860 |
Why?
| Delivery, Obstetric | 3 | 2020 | 117 | 0.850 |
Why?
| United States | 29 | 2024 | 5209 | 0.840 |
Why?
| Autistic Disorder | 2 | 2023 | 135 | 0.830 |
Why?
| Placenta | 1 | 2022 | 136 | 0.790 |
Why?
| Genetic Variation | 3 | 2021 | 253 | 0.780 |
Why?
| Live Birth | 11 | 2022 | 25 | 0.780 |
Why?
| Health Status Disparities | 3 | 2013 | 219 | 0.780 |
Why?
| Hypoplastic Left Heart Syndrome | 3 | 2023 | 97 | 0.770 |
Why?
| Hospitals, Teaching | 1 | 2020 | 58 | 0.760 |
Why?
| Young Adult | 21 | 2023 | 4319 | 0.750 |
Why?
| Public Health | 1 | 2023 | 205 | 0.750 |
Why?
| Male | 50 | 2023 | 27348 | 0.750 |
Why?
| Tobacco, Smokeless | 1 | 2020 | 27 | 0.750 |
Why?
| Cohort Studies | 10 | 2023 | 1547 | 0.730 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2019 | 8 | 0.710 |
Why?
| Hospitals | 1 | 2020 | 188 | 0.690 |
Why?
| Nicotine | 1 | 2020 | 207 | 0.670 |
Why?
| Adolescent | 21 | 2023 | 6901 | 0.650 |
Why?
| Tobacco Products | 1 | 2020 | 115 | 0.650 |
Why?
| Premature Birth | 3 | 2020 | 154 | 0.600 |
Why?
| Abnormalities, Drug-Induced | 1 | 2017 | 18 | 0.600 |
Why?
| Heart Septal Defects | 1 | 2016 | 12 | 0.580 |
Why?
| Air Pollutants | 4 | 2021 | 70 | 0.550 |
Why?
| Maternal Age | 10 | 2024 | 46 | 0.550 |
Why?
| Tetralogy of Fallot | 1 | 2016 | 94 | 0.540 |
Why?
| Developed Countries | 1 | 2015 | 12 | 0.530 |
Why?
| Emergency Treatment | 1 | 2015 | 33 | 0.530 |
Why?
| Hysterectomy | 1 | 2015 | 89 | 0.520 |
Why?
| Postpartum Hemorrhage | 1 | 2015 | 33 | 0.520 |
Why?
| Texas | 8 | 2022 | 160 | 0.500 |
Why?
| Genome-Wide Association Study | 4 | 2023 | 190 | 0.500 |
Why?
| Thoracic Surgery | 1 | 2013 | 13 | 0.480 |
Why?
| Kaplan-Meier Estimate | 6 | 2016 | 514 | 0.470 |
Why?
| Neural Tube Defects | 2 | 2023 | 30 | 0.460 |
Why?
| Western Australia | 4 | 2023 | 6 | 0.460 |
Why?
| Educational Status | 4 | 2023 | 261 | 0.450 |
Why?
| Proportional Hazards Models | 7 | 2017 | 430 | 0.450 |
Why?
| Neoplasms | 2 | 2020 | 1322 | 0.450 |
Why?
| Birth Weight | 2 | 2010 | 126 | 0.450 |
Why?
| Urinary Tract Infections | 2 | 2023 | 54 | 0.440 |
Why?
| Down Syndrome | 3 | 2024 | 100 | 0.430 |
Why?
| Infant, Premature, Diseases | 2 | 2017 | 93 | 0.430 |
Why?
| Odds Ratio | 11 | 2023 | 600 | 0.420 |
Why?
| Cleft Palate | 2 | 2023 | 72 | 0.420 |
Why?
| Australia | 3 | 2023 | 85 | 0.410 |
Why?
| Polymorphism, Single Nucleotide | 6 | 2022 | 552 | 0.400 |
Why?
| Birth Certificates | 2 | 2021 | 20 | 0.390 |
Why?
| Disabled Persons | 2 | 2023 | 105 | 0.390 |
Why?
| Anophthalmos | 2 | 2022 | 4 | 0.390 |
Why?
| Florida | 5 | 2019 | 59 | 0.390 |
Why?
| Microphthalmos | 2 | 2022 | 7 | 0.390 |
Why?
| Air Pollution | 3 | 2019 | 45 | 0.380 |
Why?
| Turner Syndrome | 2 | 2023 | 14 | 0.380 |
Why?
| Spinal Dysraphism | 2 | 2020 | 34 | 0.360 |
Why?
| Risk Assessment | 7 | 2021 | 1362 | 0.350 |
Why?
| Ultrasonography, Prenatal | 3 | 2021 | 187 | 0.350 |
Why?
| Micronesia | 2 | 2019 | 119 | 0.340 |
Why?
| Incidence | 3 | 2023 | 1084 | 0.310 |
Why?
| Cardiology | 2 | 2023 | 105 | 0.300 |
Why?
| Survival Rate | 6 | 2018 | 954 | 0.290 |
Why?
| Middle Aged | 14 | 2021 | 13083 | 0.290 |
Why?
| Hepatoblastoma | 2 | 2023 | 4 | 0.280 |
Why?
| Infant, Low Birth Weight | 2 | 2021 | 76 | 0.280 |
Why?
| Neuroblastoma | 2 | 2023 | 50 | 0.280 |
Why?
| Parturition | 3 | 2022 | 54 | 0.270 |
Why?
| Genotype | 4 | 2023 | 600 | 0.270 |
Why?
| Biliary Atresia | 2 | 2023 | 9 | 0.270 |
Why?
| Aortic Coarctation | 2 | 2023 | 32 | 0.250 |
Why?
| Alleles | 3 | 2023 | 277 | 0.250 |
Why?
| Limb Deformities, Congenital | 1 | 2024 | 11 | 0.240 |
Why?
| Esophageal Atresia | 2 | 2021 | 5 | 0.240 |
Why?
| Analysis of Variance | 2 | 2019 | 634 | 0.240 |
Why?
| Household Products | 1 | 2023 | 2 | 0.230 |
Why?
| Wilms Tumor | 1 | 2023 | 17 | 0.230 |
Why?
| Telemedicine | 2 | 2021 | 453 | 0.230 |
Why?
| Pregnancy Complications | 2 | 2019 | 387 | 0.230 |
Why?
| Socioeconomic Factors | 5 | 2023 | 639 | 0.230 |
Why?
| Mothers | 5 | 2023 | 248 | 0.220 |
Why?
| Anencephaly | 1 | 2022 | 16 | 0.220 |
Why?
| Cleft Lip | 1 | 2023 | 37 | 0.220 |
Why?
| Fetal Death | 1 | 2022 | 22 | 0.220 |
Why?
| Autopsy | 1 | 2022 | 52 | 0.220 |
Why?
| Common Cold | 1 | 2022 | 6 | 0.220 |
Why?
| Heart Septal Defects, Atrial | 1 | 2022 | 45 | 0.220 |
Why?
| Extreme Heat | 1 | 2021 | 2 | 0.210 |
Why?
| Birth Intervals | 1 | 2021 | 1 | 0.210 |
Why?
| Hydrocephalus | 1 | 2022 | 42 | 0.210 |
Why?
| Pyloric Stenosis, Hypertrophic | 1 | 2022 | 29 | 0.210 |
Why?
| Healthcare Disparities | 4 | 2023 | 269 | 0.210 |
Why?
| Liver Neoplasms | 2 | 2023 | 352 | 0.210 |
Why?
| Cluster Analysis | 1 | 2022 | 249 | 0.210 |
Why?
| Cataract | 2 | 2019 | 46 | 0.200 |
Why?
| Nitrogen Dioxide | 2 | 2019 | 8 | 0.200 |
Why?
| Energy Intake | 2 | 2020 | 196 | 0.200 |
Why?
| Kidney Neoplasms | 1 | 2023 | 197 | 0.200 |
Why?
| Inheritance Patterns | 1 | 2021 | 27 | 0.200 |
Why?
| Disinfectants | 1 | 2020 | 12 | 0.200 |
Why?
| Influenza, Human | 1 | 2022 | 120 | 0.190 |
Why?
| Term Birth | 1 | 2020 | 21 | 0.190 |
Why?
| Chromosome Disorders | 1 | 2021 | 39 | 0.190 |
Why?
| Water Pollutants, Chemical | 1 | 2020 | 55 | 0.180 |
Why?
| Digestive System Abnormalities | 1 | 2019 | 6 | 0.180 |
Why?
| Emotions | 1 | 2021 | 170 | 0.180 |
Why?
| Schools | 1 | 2021 | 177 | 0.180 |
Why?
| Ozone | 1 | 2019 | 19 | 0.180 |
Why?
| Truncus Arteriosus | 1 | 2019 | 9 | 0.180 |
Why?
| Quality of Life | 3 | 2021 | 924 | 0.180 |
Why?
| Radioactive Hazard Release | 1 | 2019 | 16 | 0.180 |
Why?
| Pregnancy, Multiple | 1 | 2019 | 22 | 0.180 |
Why?
| Diacylglycerol Kinase | 1 | 2019 | 6 | 0.180 |
Why?
| Health Services | 1 | 2020 | 80 | 0.180 |
Why?
| Gene Regulatory Networks | 1 | 2020 | 124 | 0.180 |
Why?
| Fetal Diseases | 1 | 2020 | 62 | 0.170 |
Why?
| Gene-Environment Interaction | 1 | 2019 | 44 | 0.170 |
Why?
| Urinalysis | 1 | 2019 | 50 | 0.170 |
Why?
| Dietary Fats | 1 | 2020 | 142 | 0.170 |
Why?
| Substance Abuse Detection | 1 | 2019 | 92 | 0.170 |
Why?
| Logistic Models | 5 | 2023 | 991 | 0.170 |
Why?
| Abortion, Induced | 1 | 2018 | 20 | 0.170 |
Why?
| Chi-Square Distribution | 1 | 2019 | 318 | 0.170 |
Why?
| Age Factors | 2 | 2020 | 1199 | 0.170 |
Why?
| Emigrants and Immigrants | 1 | 2019 | 39 | 0.170 |
Why?
| Cross-Sectional Studies | 3 | 2022 | 1697 | 0.170 |
Why?
| Cannabis | 1 | 2021 | 149 | 0.170 |
Why?
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 12 | 0.160 |
Why?
| Occupational Exposure | 1 | 2020 | 129 | 0.160 |
Why?
| Education, Medical, Graduate | 1 | 2020 | 226 | 0.160 |
Why?
| Cause of Death | 3 | 2017 | 164 | 0.160 |
Why?
| Binge Drinking | 1 | 2018 | 28 | 0.160 |
Why?
| Multivariate Analysis | 1 | 2019 | 643 | 0.160 |
Why?
| Genotyping Techniques | 1 | 2017 | 26 | 0.150 |
Why?
| Genetic Testing | 1 | 2018 | 135 | 0.150 |
Why?
| Smoking Cessation | 1 | 2020 | 313 | 0.150 |
Why?
| Eating | 1 | 2017 | 163 | 0.150 |
Why?
| Follow-Up Studies | 4 | 2023 | 2390 | 0.140 |
Why?
| Gastrointestinal Diseases | 1 | 2017 | 134 | 0.140 |
Why?
| Particulate Matter | 3 | 2021 | 56 | 0.140 |
Why?
| DNA Methylation | 1 | 2020 | 575 | 0.140 |
Why?
| Interviews as Topic | 1 | 2017 | 314 | 0.140 |
Why?
| Peripartum Period | 1 | 2015 | 17 | 0.130 |
Why?
| Confidence Intervals | 2 | 2016 | 166 | 0.130 |
Why?
| Maternal Mortality | 1 | 2015 | 25 | 0.130 |
Why?
| Comorbidity | 3 | 2023 | 664 | 0.130 |
Why?
| Gene Expression Profiling | 1 | 2020 | 1141 | 0.130 |
Why?
| Residence Characteristics | 2 | 2014 | 166 | 0.130 |
Why?
| Diet | 1 | 2019 | 598 | 0.130 |
Why?
| Starvation | 1 | 2014 | 10 | 0.120 |
Why?
| Hypertension | 2 | 2014 | 565 | 0.120 |
Why?
| Health Services Accessibility | 2 | 2023 | 428 | 0.120 |
Why?
| Public Health Surveillance | 1 | 2013 | 13 | 0.120 |
Why?
| Sex Factors | 4 | 2017 | 766 | 0.120 |
Why?
| Environmental Exposure | 3 | 2023 | 205 | 0.110 |
Why?
| Heart Diseases | 2 | 2014 | 239 | 0.110 |
Why?
| Survival Analysis | 2 | 2014 | 736 | 0.110 |
Why?
| Substance-Related Disorders | 1 | 2019 | 671 | 0.110 |
Why?
| Time-to-Treatment | 1 | 2013 | 74 | 0.110 |
Why?
| Exome | 2 | 2023 | 51 | 0.110 |
Why?
| Pesticides | 1 | 2012 | 22 | 0.110 |
Why?
| Research Design | 1 | 2015 | 375 | 0.110 |
Why?
| Poverty | 1 | 2014 | 231 | 0.110 |
Why?
| Respiratory Sounds | 1 | 2012 | 54 | 0.110 |
Why?
| Acculturation | 1 | 2012 | 23 | 0.110 |
Why?
| Cough | 1 | 2012 | 55 | 0.110 |
Why?
| Referral and Consultation | 1 | 2014 | 308 | 0.100 |
Why?
| Thiazolidinediones | 1 | 2012 | 95 | 0.100 |
Why?
| Chlorophenols | 1 | 2011 | 1 | 0.100 |
Why?
| Fractures, Bone | 1 | 2012 | 118 | 0.100 |
Why?
| Anticonvulsants | 1 | 2012 | 129 | 0.100 |
Why?
| Academic Medical Centers | 1 | 2012 | 146 | 0.100 |
Why?
| Hypoglycemic Agents | 1 | 2012 | 177 | 0.100 |
Why?
| Infant, Premature | 2 | 2017 | 337 | 0.090 |
Why?
| Infant, Very Low Birth Weight | 1 | 2010 | 47 | 0.090 |
Why?
| Counseling | 2 | 2023 | 147 | 0.090 |
Why?
| Folic Acid | 2 | 2023 | 139 | 0.090 |
Why?
| South America | 2 | 2019 | 9 | 0.090 |
Why?
| Asia | 2 | 2019 | 32 | 0.090 |
Why?
| Patient Acceptance of Health Care | 2 | 2023 | 331 | 0.090 |
Why?
| Epilepsy | 1 | 2012 | 191 | 0.090 |
Why?
| Cognition | 2 | 2023 | 350 | 0.090 |
Why?
| North America | 2 | 2019 | 70 | 0.090 |
Why?
| Europe | 2 | 2019 | 102 | 0.090 |
Why?
| Disease Susceptibility | 1 | 2009 | 95 | 0.090 |
Why?
| Sex Distribution | 1 | 2009 | 159 | 0.090 |
Why?
| Fetal Growth Retardation | 1 | 2009 | 45 | 0.080 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2011 | 231 | 0.080 |
Why?
| Fetal Development | 1 | 2009 | 64 | 0.080 |
Why?
| Nutritional Status | 2 | 2020 | 158 | 0.080 |
Why?
| Morbidity | 1 | 2009 | 149 | 0.080 |
Why?
| Georgia | 3 | 2021 | 40 | 0.080 |
Why?
| Abnormalities, Multiple | 2 | 2019 | 162 | 0.080 |
Why?
| Time Factors | 3 | 2019 | 3210 | 0.070 |
Why?
| Heart Failure | 1 | 2012 | 541 | 0.070 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2012 | 486 | 0.070 |
Why?
| Aged | 4 | 2021 | 10061 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2021 | 1301 | 0.070 |
Why?
| Analgesia, Epidural | 1 | 2004 | 26 | 0.060 |
Why?
| Analgesia, Obstetrical | 1 | 2004 | 25 | 0.060 |
Why?
| Prejudice | 1 | 2004 | 43 | 0.060 |
Why?
| Neural Crest | 1 | 2023 | 1 | 0.060 |
Why?
| Cerebral Ventricles | 1 | 2023 | 25 | 0.060 |
Why?
| Calpain | 1 | 2023 | 28 | 0.060 |
Why?
| Reproductive Health | 1 | 2023 | 10 | 0.060 |
Why?
| Homozygote | 1 | 2023 | 60 | 0.060 |
Why?
| Workplace | 1 | 2004 | 98 | 0.060 |
Why?
| Contraception | 1 | 2023 | 29 | 0.060 |
Why?
| Models, Genetic | 1 | 2023 | 209 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 253 | 0.050 |
Why?
| Vitamins | 1 | 2022 | 72 | 0.050 |
Why?
| Seroepidemiologic Studies | 1 | 2022 | 50 | 0.050 |
Why?
| Aorta | 1 | 2023 | 177 | 0.050 |
Why?
| Data Collection | 1 | 2023 | 320 | 0.050 |
Why?
| Mutation, Missense | 1 | 2022 | 117 | 0.050 |
Why?
| Stress, Psychological | 1 | 2004 | 270 | 0.050 |
Why?
| Medicaid | 1 | 2004 | 268 | 0.050 |
Why?
| Fever | 1 | 2022 | 129 | 0.050 |
Why?
| Cardiomyopathy, Hypertrophic, Familial | 1 | 2021 | 6 | 0.050 |
Why?
| Arizona | 1 | 2021 | 14 | 0.050 |
Why?
| Cities | 1 | 2021 | 20 | 0.050 |
Why?
| Trihalomethanes | 1 | 2020 | 1 | 0.050 |
Why?
| Disinfection | 1 | 2020 | 12 | 0.050 |
Why?
| Chromosome Mapping | 1 | 2021 | 175 | 0.050 |
Why?
| Membrane Proteins | 1 | 2023 | 389 | 0.050 |
Why?
| CpG Islands | 1 | 2020 | 104 | 0.050 |
Why?
| Delivery of Health Care | 1 | 2023 | 325 | 0.050 |
Why?
| Nutritive Value | 1 | 2020 | 39 | 0.050 |
Why?
| Sulfur Dioxide | 1 | 2019 | 3 | 0.050 |
Why?
| Abdominal Wall | 1 | 2019 | 10 | 0.050 |
Why?
| Laboratories, Hospital | 1 | 2019 | 6 | 0.050 |
Why?
| Parents | 1 | 2023 | 346 | 0.040 |
Why?
| Jamaica | 1 | 2019 | 9 | 0.040 |
Why?
| Amphetamines | 1 | 2019 | 28 | 0.040 |
Why?
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 51 | 0.040 |
Why?
| Particle Size | 1 | 2019 | 88 | 0.040 |
Why?
| Bayes Theorem | 1 | 2019 | 125 | 0.040 |
Why?
| Health Services Needs and Demand | 1 | 2021 | 190 | 0.040 |
Why?
| Chromosome Aberrations | 1 | 2021 | 316 | 0.040 |
Why?
| Benzodiazepines | 1 | 2019 | 70 | 0.040 |
Why?
| Needs Assessment | 1 | 2020 | 153 | 0.040 |
Why?
| Ear | 1 | 2018 | 20 | 0.040 |
Why?
| Mortality | 1 | 2019 | 102 | 0.040 |
Why?
| Eye Abnormalities | 1 | 2018 | 22 | 0.040 |
Why?
| Temperature | 1 | 2019 | 177 | 0.040 |
Why?
| Dietary Supplements | 1 | 2022 | 457 | 0.040 |
Why?
| Hematologic Neoplasms | 1 | 2020 | 100 | 0.040 |
Why?
| Methadone | 1 | 2019 | 169 | 0.040 |
Why?
| Fetus | 1 | 2020 | 228 | 0.040 |
Why?
| Cocaine | 1 | 2019 | 184 | 0.040 |
Why?
| Intestinal Atresia | 1 | 2017 | 5 | 0.040 |
Why?
| Family | 1 | 2019 | 191 | 0.040 |
Why?
| Tracheoesophageal Fistula | 1 | 2017 | 11 | 0.040 |
Why?
| Vitamin B 6 | 1 | 2017 | 11 | 0.040 |
Why?
| Algorithms | 1 | 2022 | 697 | 0.040 |
Why?
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 9 | 0.040 |
Why?
| Diet Records | 1 | 2017 | 24 | 0.040 |
Why?
| Lung Diseases | 1 | 2018 | 86 | 0.040 |
Why?
| Phenotype | 1 | 2021 | 819 | 0.040 |
Why?
| Vitamin B 12 | 1 | 2017 | 28 | 0.040 |
Why?
| Food Analysis | 1 | 2017 | 37 | 0.040 |
Why?
| Choline | 1 | 2017 | 64 | 0.040 |
Why?
| Anti-Bacterial Agents | 1 | 2023 | 825 | 0.040 |
Why?
| Buprenorphine | 1 | 2019 | 135 | 0.040 |
Why?
| Pandemics | 1 | 2022 | 594 | 0.040 |
Why?
| Colon | 1 | 2017 | 111 | 0.040 |
Why?
| Smoking | 1 | 2021 | 553 | 0.040 |
Why?
| Epigenesis, Genetic | 1 | 2020 | 399 | 0.040 |
Why?
| Hypertension, Pulmonary | 1 | 2018 | 126 | 0.040 |
Why?
| Quebec | 1 | 2016 | 13 | 0.040 |
Why?
| Methionine | 1 | 2017 | 146 | 0.040 |
Why?
| Gastrointestinal Tract | 1 | 2017 | 136 | 0.030 |
Why?
| Decision Making | 1 | 2018 | 286 | 0.030 |
Why?
| Monte Carlo Method | 1 | 2016 | 99 | 0.030 |
Why?
| Body Mass Index | 1 | 2019 | 712 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2020 | 1063 | 0.030 |
Why?
| Lung | 1 | 2018 | 508 | 0.030 |
Why?
| Neonatal Screening | 1 | 2015 | 50 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 922 | 0.030 |
Why?
| Databases, Factual | 1 | 2017 | 683 | 0.030 |
Why?
| Analgesics, Opioid | 1 | 2019 | 500 | 0.030 |
Why?
| China | 1 | 2014 | 104 | 0.030 |
Why?
| Oximetry | 1 | 2014 | 62 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2017 | 1082 | 0.030 |
Why?
| Cardiac Surgical Procedures | 1 | 2016 | 318 | 0.030 |
Why?
| Health Surveys | 1 | 2014 | 262 | 0.030 |
Why?
| Nutrition Surveys | 1 | 2012 | 122 | 0.030 |
Why?
| Biomedical Research | 1 | 2015 | 241 | 0.030 |
Why?
| Body Burden | 1 | 2011 | 12 | 0.030 |
Why?
| Epidemiological Monitoring | 1 | 2011 | 10 | 0.030 |
Why?
| Epidemiologic Methods | 1 | 2011 | 49 | 0.030 |
Why?
| Critical Illness | 1 | 2014 | 344 | 0.020 |
Why?
| Environmental Monitoring | 1 | 2011 | 71 | 0.020 |
Why?
| Prognosis | 1 | 2015 | 2126 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3431 | 0.020 |
Why?
| Heart Ventricles | 1 | 2010 | 271 | 0.020 |
Why?
| Animals | 1 | 2023 | 14411 | 0.020 |
Why?
| Treatment Outcome | 1 | 2016 | 5612 | 0.020 |
Why?
| Labor, Obstetric | 1 | 2004 | 41 | 0.020 |
Why?
| Urban Health | 1 | 2004 | 36 | 0.020 |
Why?
|
|
Nembhard's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|